Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3002814	s-trspab	— (—)	46	48	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

8.35

14.80

1.0

1.1

—

Other diseases of blood and blood-forming organs, wide

30.04

11.63

1.0

—

ILD medications

5.69

8.92

1.0

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

5.89

8.88

1.0

1.1

—

First line medication for Crohn's disease

5.40

8.11

1.0

1.1

—

Oral corticosteroids

4.90

7.33

1.1

1.0

—

Asthma

9.32

7.05

1.1

1.0

—

Asthma, excluding more controls

9.27

7.02

1.1

1.0

—

General symptoms and signs

5.30

6.93

1.1

1.0

—

Asthma (mode)

8.92

6.55

1.1

1.0

—

Asthma (only as main-diagnosis)

9.00

6.31

1.1

1.0

—

Asthma, unspecified (mode)

10.36

5.76

1.2

1.0

—

Asthma, unspecified (mode), excluding more controls

10.29

5.73

1.2

1.0

—

Asthma (only as main-diagnosis), excluding more controls

8.26

5.64

1.1

1.0

—

Inflammatory bowel disease treatment related agents

4.03

5.51

1.1

1.0

—

Asthma (diagnoses ohter than nonallergic)

4.91

5.31

1.1

1.0

—

Abnormal findings on diagnostic imaging of lung

7.99

4.90

1.0

—

Chronic lower respiratory diseases

3.69

4.88

1.1

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

5.96

4.79

1.0

—

Dermatitis and eczema

3.63

4.78

1.1

1.0

—

Other diseases of intestines

3.79

4.61

1.1

1.0

—

Other functional intestinal disorders

8.35

4.54

1.1

1.0

—

Asthma, hospital admissions , main diagnosis only

4.57

4.50

1.1

1.0

—

Asthma, including avohilmo

3.41

4.26

1.1

1.0

—

ILD medications: immunosuppressive drugs

6.19

4.21

1.0

1.1

—

Malaise and fatigue

8.05

3.90

1.1

1.0

—

Dermatitis

4.77

3.85

1.1

1.0

—

Other and unspecified dermatitis

5.26

3.82

1.1

—

Fever of other and unknown origin

6.16

3.80

1.1

1.0

—

Acute upper respiratory infections

3.19

3.33

1.1

1.0

—

Vasomotor and allergic rhinitis

5.61

3.28

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

8.58

3.26

1.0

—

Colonic or urogenital fistula

8.57

3.26

1.0

—

Irritable bowel syndrome

8.57

3.26

1.2

1.0

—

L04AX Other immunosuppressants

4.17

3.19

1.0

1.1

—

Urticaria and erythema

6.36

3.18

1.0

—

5.29

3.16

1.3

1.0

—

Syncope and collapse

8.56

3.16

1.0

—

Second line medication for Crohn's disease

4.00

3.08

1.0

1.1

—

Fissure and fistula of anal and rectal regions

10.00

2.98

1.0

—

Other systemic involvement of connective tissue

6.67

2.86

1.0

—

Conjunctivitis (acute, non atopic)

6.64

2.86

1.0

—

Gastro-oesophageal reflux disease

3.75

2.85

1.0

—

Pain in joint

4.41

2.84

1.0

—

Diseases of oesophagus, stomach and duodenum

2.99

2.80

1.1

1.0

—

Cough

4.45

2.77

1.1

—

Systemic connective tissue disorders

5.00

2.72

1.0

—

Asthma/COPD (KELA code 203)

3.16

2.70

1.1

1.0

—

Asthma, hospital admission 2, infections

4.12

2.62

1.3

1.0

—

Asthma-related infections

4.12

2.62

1.3

1.0

—

Intestinal infectious diseases

2.84

2.56

1.2

1.0

—

Atopic dermatitis

3.69

2.55

1.1

—

Liquid cancers, helper endpoint

4.70

2.55

1.0

—

Recurrent or chronic depression

4.92

2.54

1.0

—

Disturbances of skin sensation

5.46

2.54

1.0

—

Other pulmonary diagnosis

4.45

2.46

1.0

—

Excluding asthma or asthma-COPD overlap

4.45

2.46

1.0

—

COPD differential diagnosis

4.45

2.46

1.0

—

ILD differential diagnosis

4.45

2.46

1.0

—

Persons encountering health services in other circumstances

4.35

2.46

1.0

—

Disorders of skin appendages

3.81

2.45

1.0

—

2.68

2.43

1.1

1.0

—

Diaphragmatic hernia

5.00

2.40

1.0

—

Allergic rhinitis

4.94

2.38

1.2

1.0

—

Acute pancreatitis (for exclusion)

6.25

2.37

1.0

—

Intestinal infectious diseases

2.58

2.35

1.1

1.0

—

Medical observation and evaluation for suspected diseases and conditions

4.09

2.32

1.0

1.1

—

Other and unspecified anaemias

4.76

2.30

1.0

—

Other anaemias

4.75

2.30

1.0

—

Aplastic and other anaemias

4.66

2.26

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

2.64

2.25

1.1

1.0

—

Autoimmune diseases excluding thyroid diseases

2.63

2.23

1.1

1.0

—

Acute pancreatitis

5.56

2.21

1.0

—

Other enthesopathies

5.56

2.21

1.2

1.0

—

Obesity related asthma

5.56

2.21

1.2

1.0

—

Other systemic involvement of connective tissue (FG)

5.48

2.19

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3.78

2.18

1.0

1.1

—

Diseases of the respiratory system

4.38

2.18

1.0

—

Diseases of liver

5.00

2.07

1.2

1.0

—

Inflammatory diseases of female pelvic organs

3.27

2.05

1.1

—

Disorders of lacrimal system

3.99

2.03

1.0

1.1

—

Low back pain

2.94

2.01

1.1

1.0

—

Other intervertebral disc disorders

3.01

2.00

1.0

1.1

—

Autoimmune diseases related-to ILD

2.67

2.00

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.47

1.96

1.2

1.0

—

GASTRO-related operations

3.34

1.96

1.0

—

Any gastric operation

3.34

1.96

1.0

—

Episodal and paroxysmal disorders

2.45

1.94

1.1

1.0

—

Disorders of adult personality and behaviour

4.55

1.94

1.2

1.0

—

Urticaria

4.55

1.94

1.0

—

4.58

1.92

1.0

—

Other and unspecified tonsillitis

4.67

1.92

1.0

—

Migraine

3.34

1.91

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.70

1.88

1.2

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

4.73

1.86

1.0

1.1

—

Persons encountering health services for examination and investigation

3.51

1.84

1.0

1.1

—

Sleep disorders (combined)

2.35

1.82

1.1

1.0

—

Inflammatory bowel disease

4.17

1.82

1.0

—

Other disorders of lacrimal gland

4.17

1.82

1.0

—

Chronic sinusitis

3.84

1.71

1.2

1.1

—

Lumbar disc prolapse

2.98

1.70

1.0

1.1

—

Gastrointestinal diseases

3.19

1.69

1.0

—

Pain (limb, back, neck, head abdominally)

2.86

1.68

1.0

—

Certain infectious and parasitic diseases

2.86

1.68

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

2.69

1.68

1.1

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

2.61

1.67

1.0

1.1

—

Noninfective enteritis and colitis

3.15

1.66

1.0

—

Acute appendicitis, no complications

2.79

1.64

1.3

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.95

1.63

1.0

—

Other reaction to severe stress, and adjustment disorders

3.57

1.61

1.2

1.1

—

Diseases of the musculoskeletal system and connective tissue

3.34

1.57

1.0

—

Caries of enamel

2.33

1.56

1.1

1.0

—

Papulosquamous disorders

3.33

1.52

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

2.59

1.51

1.1

1.0

—

Dental operations

3.08

1.47

1.0

—

Acute sinusitis

2.78

1.45

1.2

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

3.04

1.44

1.0

1.1

—

Certain infectious and parasitic diseases

2.38

1.44

1.1

1.0

—

Diseases of the digestive system

3.11

1.43

1.0

—

COPD/asthma/ILD related infections

2.20

1.36

1.1

1.0

—

COPD/asthma related infections

2.20

1.36

1.1

1.0

—

Diseases of oral cavity, salivary glands and jaws

2.81

1.34

1.0

—

Bacterial infection, other or unspecified

2.60

1.34

1.2

1.0

—

Lower back pain or/and sciatica

2.11

1.33

1.1

1.0

—

Bacterial infection, other or unspecified

2.54

1.30

1.2

1.0

—

Rotator cuff syndrome

2.53

1.27

1.0

—

Infections with a predominantly sexual mode of transmission

2.74

1.25

1.0

—

Examination and observation for other reasons

2.89

1.24

1.0

1.1

—

Tramadol

2.23

1.22

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2.63

1.21

1.2

1.1

—

Autoimmune diseases

2.07

1.20

1.0

—

Venous thromboembolism

2.54

1.16

1.0

—

External causes of morbidity and mortality

2.51

1.16

1.0

1.1

—

Other anxiety disorders

2.55

1.15

1.0

1.1

—

Other specific joint derangements/joint disorders

2.07

1.13

1.0

1.1

—

Shoulder lesions

2.36

1.12

1.0

—

Disorders of conjunctiva

2.01

1.11

1.0

1.1

—

Dorsalgia

2.10

1.08

1.0

—

Pain in throat and chest

2.08

1.08

1.1

1.0

—

Neurological diseases

2.06

1.07

1.0

—

Other dorsopathies, not elsewhere classified

2.05

1.07

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.05

1.06

1.0

—

Other diseases of upper respiratory tract

2.00

1.03

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.94

1.02

1.0

—

Acute appendicitis

2.04

1.02

1.3

1.0

—

Injury, poisoning and certain other consequences of external causes

2.51

0.99

1.0

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.86

0.98

1.0

1.1

—

Open wound of head

2.19

0.98

1.0

—

Chronic diseases of tonsils and adenoids

2.01

0.98

1.1

1.0

—

Soft tissue disorders

1.85

0.97

1.0

—

Finngen Rheumatological endpoints

1.83

0.96

1.0

1.1

—

Appendicitis, broad definition

1.92

0.95

1.3

1.0

—

Diseases of appendix

1.91

0.94

1.3

1.0

—

Appendectomy

2.21

0.93

1.2

1.0

—

Conjunctivitis

1.89

0.92

1.0

1.1

—

All anxiety disorders

2.15

0.91

1.0

—

Triptan medication for migraine, min. 3 purchases

2.08

0.89

1.0

1.1

—

Sleep disorders

1.86

0.87

1.0

1.1

—

Diseases of pulp and periapical tissues and dental caries

2.05

0.86

1.0

—

Implicit Sepsis

1.83

0.86

1.0

—

Anxiety disorders, excluding more controls

1.79

0.84

1.1

1.0

—

Persons encountering health services in other circumstances, wide

1.84

0.84

1.0

—

Disorders of lens

1.97

0.84

1.0

1.1

—

Neurotic, stress-related and somatoform disorders

1.75

0.82

1.1

1.0

—

Anxiety disorders

1.74

0.82

1.1

1.0

—

Constipation

1.73

0.81

1.0

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.72

0.80

1.0

1.1

—

All-cause Heart Failure

0.00

0.80

0.0

1.0

—

Heart failure,strict

0.00

0.80

0.0

1.0

—

Heart failure, strict

0.00

0.80

0.0

1.0

—

Excessive earwax

0.00

0.79

0.0

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.00

0.78

0.0

1.0

—

Arthropathies

1.75

0.78

1.0

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

1.73

0.77

1.0

—

Exposure to unspecified factor

1.75

0.77

1.1

1.0

—

Complications of medical and surgical care

1.78

0.76

1.0

1.1

—

Senile cataract

2.19

0.76

1.0

—

Parasetamol

1.87

0.74

1.0

—

Diseases of inner ear

2.01

0.73

1.0

—

Bronchitis

1.62

0.72

1.1

1.0

—

Disorders of sclera, cornea, iris and ciliary body

2.00

0.72

1.2

1.0

—

Diverticular disease of intestine

1.99

0.72

1.2

1.0

—

Disorders of eyelid, lacrimal system and orbit

1.77

0.72

1.0

1.1

—

Injuries to the head

1.71

0.71

1.1

1.0

—

Diseases of arteries, arterioles and capillaries

1.94

0.70

1.0

—

Other soft tissue disorders, not elsewhere classified

1.71

0.69

1.0

—

Insomnia

1.70

0.69

1.0

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.83

0.67

1.0

1.1

—

Anxiety (asthma-related co-morbidities)

1.84

0.67

1.0

—

Diseases of the eye and adnexa

1.67

0.67

1.0

—

Abdominal and pelvic pain

1.75

0.65

1.0

—

Cardiovascular diseases

1.79

0.64

1.0

—

Disorders of gallbladder, biliary tract and pancreas

1.68

0.63

1.1

1.0

—

Spondylopathies

1.76

0.63

1.0

1.1

—

Hyperplasia of prostate

0.00

0.63

0.0

1.0

—

Other antidepressants

1.64

0.63

1.1

1.0

—

Heart failure and coronary heart disease

0.00

0.62

0.0

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.60

0.61

1.0

1.1

—

Sleep apnoea, including avohilmo

1.60

0.61

1.1

1.0

—

Mood disorders, excluding more controls

1.59

0.61

1.1

1.0

—

Other abnormal products of conception

0.00

0.61

0.0

1.1

—

Dental caries, including avohilmo

1.81

0.60

1.0

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.55

0.60

1.1

1.0

—

Persons with potential health hazards related to communicable diseases

0.00

0.59

0.0

1.0

—

Implicit Sepsis

1.74

0.58

1.0

—

Injuries to the ankle and foot

1.72

0.58

1.0

1.1

—

Bleeding

1.71

0.57

1.0

—

Neoplasms

1.67

0.57

1.0

—

Dizziness and giddiness

1.64

0.56

1.0

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

1.57

0.53

1.0

1.1

—

Cholelithiasis

1.53

0.52

1.2

1.0

—

Diseases of the skin and subcutaneous tissue

1.60

0.50

1.0

—

Dorsopathies

1.55

0.49

1.0

—

Viral infections characterized by skin and mucous membrane lesions

1.53

0.48

1.0

1.1

—

Sleep apnoea

1.51

0.48

1.1

1.0

—

Codeine

1.46

0.47

1.0

—

Selective serotonin reuptake inhibitors

1.46

0.47

1.0

—

Depression or dysthymia

1.62

0.43

1.0

—

Persons encountering health services for specific procedures and health care

1.41

0.42

1.1

1.0

—

Other disorders of urethra and urinary system

1.57

0.42

1.2

1.0

—

Hypothyroidism, strict autoimmune

1.57

0.42

1.0

—

Mood [affective] disorders

1.40

0.42

1.1

1.0

—

Mood disorders

1.40

0.42

1.1

1.0

—

Supervision of high-risk pregnancy

0.00

0.42

0.0

1.0

—

Gestational diabetes (for exclusion)

0.00

0.42

0.0

1.1

—

Conduction disorders

0.00

0.41

0.0

1.0

—

Embedded and impacted teeth

0.00

0.41

0.0

1.0

—

Care involving use of rehabilitation procedures

1.53

0.41

1.2

1.0

—

Acute suppurative otitis media

0.00

0.41

0.0

1.0

—

Diabetes mellitus in pregnancy

0.00

0.41

0.0

1.1

—

Cardiodefibrillation

0.00

0.41

0.0

1.0

—

Nonsuppurative otitis media

0.00

0.41

0.0

1.0

—

Dentofacial anomalies [including malocclusion]

1.49

0.40

1.0

1.1

—

Abrasion of teeth

0.00

0.40

0.0

1.1

—

Contact with and exposure to communicable diseases

0.00

0.40

0.0

1.0

—

Antihypertensive medication - note that there are other indications

1.47

0.40

1.0

1.1

—

Renal failure

0.00

0.40

0.0

1.0

—

Fall on same level

1.40

0.40

1.1

1.0

—

Internal derangement of knee

0.00

0.40

0.0

1.1

—

Arthrosis

1.44

0.39

1.0

1.1

—

Ischaemic heart disease, wide definition

1.41

0.38

1.0

—

Pain in limb

1.39

0.38

1.2

1.0

—

Other external causes of accidental injury

1.50

0.37

1.0

1.1

—

Accidents

1.50

0.37

1.0

1.1

—

Triptan medication for migraine, single purchase ok

1.45

0.36

1.0

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.45

0.36

1.0

1.1

—

Cholelithiasis, broad definition with cholecystitis

1.44

0.36

1.2

1.0

—

Exposure to other specified factors

1.45

0.36

1.0

1.1

—

Hypertension, essential

1.41

0.36

1.2

1.0

—

Other joint disorders

1.42

0.33

1.0

1.1

—

Opioids

1.40

0.32

1.0

—

Depression

1.35

0.31

1.1

1.0

—

Type 2 diabetes

1.32

0.31

1.3

1.0

—

Used for control exclusion in common control thyroid runs

1.31

0.31

1.0

—

Gingivitis and periodontal diseases

1.29

0.30

1.0

1.1

—

Falls/tendency to fall

1.34

0.29

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

1.37

0.24

1.0

—

Pure hypercholesterolaemia

1.36

0.24

1.2

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

1.24

0.22

1.2

1.0

—

Caries of dentine, including avohilmo

1.22

0.22

1.0

—

Symptoms and signs involving the urinary system

1.23

0.22

1.2

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.21

0.22

1.0

—

1.21

0.22

1.0

—

Heart failure and bmi 25plus

0.00

0.22

0.0

1.0

—

Degenerative diseases of the nervous system

0.00

0.22

0.0

1.0

—

Hypertensive heart and/or renal disease

0.00

0.22

0.0

1.0

—

Hypertensive Heart Disease

0.00

0.22

0.0

1.0

—

Long labour

0.00

0.21

0.0

1.1

—

Postpartum hemorraghe, parous women as controls

0.00

0.21

0.0

1.2

—

Pacemaker

0.00

0.21

0.0

1.0

—

Chronic kidney disease

0.00

0.21

0.0

1.0

—

Medical treatment for female infertility

0.00

0.21

0.0

1.1

—

Gestational [pregnancy-induced] hypertension

0.00

0.21

0.0

1.1

—

Migraine without aura and triptan purchases

0.00

0.21

0.0

1.0

—

Otitis externa

0.00

0.21

0.0

1.0

—

Cellulitis

0.00

0.21

0.0

1.0

—

Pedal cyclist injured in transport accident

0.00

0.21

0.0

1.0

—

Tinnitus

0.00

0.21

0.0

1.0

—

Gout, idiopatic and unspecified

0.00

0.21

0.0

1.0

—

Thyrotoxicosis

0.00

0.21

0.0

1.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

0.21

0.0

1.0

—

Other strabismus

0.00

0.21

0.0

1.0

—

Speech therapy

0.00

0.21

0.0

1.0

—

Other/unspecified seropositive rheumatoid arthritis

0.00

0.21

0.0

1.0

—

Superficial injury of lower leg

0.00

0.21

0.0

1.0

—

Seropositive rheumatoid arthritis, wide

0.00

0.21

0.0

1.0

—

Strabismus

0.00

0.21

0.0

1.0

—

Deforming dorsopathies

0.00

0.21

0.0

1.0

—

Gout, FINNGEN

0.00

0.21

0.0

1.0

—

Symptoms and signs involving the digestive system and abdomen

1.31

0.21

1.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

0.21

0.0

1.0

—

Melanocytic naevi

0.00

0.21

0.0

1.0

—

Diseases of external ear

0.00

0.21

0.0

1.0

—

Sequelae of cerebrovascular disease

0.00

0.21

0.0

1.0

—

Postpartum care and examination

0.00

0.21

0.0

1.0

—

Pregnancy examination and test

0.00

0.21

0.0

1.0

—

Outcome of delivery

0.00

0.21

0.0

1.0

—

Non-ischemic cardiomyopathy

0.00

0.21

0.0

1.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

0.00

0.21

0.0

1.0

—

Keratitis

0.00

0.21

0.0

1.0

—

Impacted teeth

0.00

0.20

0.0

1.0

—

Postpartum hemorraghe, all women as controls

0.00

0.20

0.0

1.1

—

Haemorrhage in early pregnancy

0.00

0.20

0.0

1.1

—

Postpartum haemorrhage

0.00

0.20

0.0

1.2

—

Covid-19 confirmed case

0.00

0.20

0.0

1.0

—

Fracture at wrist and hand level

0.00

0.20

0.0

1.0

—

Oxycodone

0.00

0.20

0.0

1.0

—

Chronic periodontitis, including avohilmo

1.22

0.20

1.0

1.1

—

Periodontitis

1.22

0.20

1.0

1.1

—

Benign neoplasms

1.18

0.20

1.0

—

Nerve, nerve root and plexus disorders

1.19

0.20

1.2

1.0

—

Other diseases of urinary system

1.16

0.19

1.0

—

Diabetes, varying definitions

1.24

0.19

1.3

1.0

—

Diabetes mellitus

1.24

0.19

1.3

1.0

—

Hypertensive diseases

1.18

0.10

1.2

1.0

—

Hypertension

1.18

0.10

1.2

1.0

—

Major coronary heart disease event

1.16

0.10

1.2

1.0

—

Hard cardiovascular diseases

1.15

0.10

1.2

1.0

—

Malignant neoplasm

1.14

0.10

1.2

1.0

—

Abnormalities of breathing

1.12

0.10

1.0

—

Artrosis, including avohilmo

1.09

0.10

1.0

1.1

—

Malignant neoplasm, wide definition for exclusion

1.09

0.10

1.2

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.09

0.09

1.0

1.1

—

Artificial joint operation, meniscal resection

1.08

0.09

1.0

1.1

—

Renal tubulo-interstitial diseases

1.06

0.09

1.0

1.1

—

Mycoses

1.06

0.09

1.0

—

Hernia

1.05

0.09

1.0

1.1

—

Metabolic disorders

1.14

0.09

1.2

1.0

—

Type 2 diabetes, strict (exclude DM1)

1.14

0.09

1.2

1.0

—

Type 2 diabetes, definitions combined

1.14

0.09

1.2

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

1.13

0.09

1.2

1.0

—

Complications of surgical and medical care, not elsewhere classified

1.14

0.09

1.0

1.1

—

Other bacterial diseases

1.12

0.09

1.2

1.0

—

Other heart diseases, wide

1.11

0.09

1.0

1.1

—

Benzodiazepine use

1.12

0.09

1.0

1.1

—

All kidney diseases

1.08

0.09

1.0

1.1

—

Diabetes medication

1.05

0.08

1.3

1.0

—

Influenza and pneumonia

0.79

0.08

1.0

1.1

—

Codeine or tramadol medication

1.13

0.08

1.0

1.1

—

Diseases of the ear and mastoid process

0.84

0.08

1.0

1.1

—

Benign neoplasm: Colon, unspecified

0.00

0.0

1.0

—

Other respiratory disorders and diseases

0.00

0.0

1.0

—

Tooth eruption problems

0.00

0.0

1.0

—

Ulcer of lower limb, not elsewhere classified

0.00

0.0

1.0

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

0.0

1.0

—

Type 1 diabetes, strict definition

0.00

0.0

1.0

—

Nephropathy related operations

0.00

0.0

1.0

—

Gout, strict definition

0.00

0.0

1.0

—

Type 1 diabetes, definitions combined

0.00

0.0

1.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.00

0.0

1.0

—

Heartburn

0.00

0.0

1.0

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.0

1.0

—

Superficial injury of forearm

0.00

0.0

1.0

—

Use of memantine

0.00

0.0

1.0

—

Other condition

0.00

0.0

1.0

—

Familial hypercholesterolemia

0.00

0.0

1.0

—

Use of other anti-dementia drugs

0.00

0.0

1.0

—

Dental pulpitis, including avohilmo

0.90

0.00

1.2

1.0

—

Car occupant injured in other and unspecified transport accidents

0.00

0.0

1.0

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.0

1.0

—

Disorders of the thyroid gland

0.96

0.00

1.0

1.1

—

Myopia

0.00

0.0

1.0

—

Acute renal failure

0.00

0.0

1.0

—

Cholecystitis

0.00

0.0

1.0

—

Colorectal adenocarcinoma

0.00

0.0

1.0

—

Focal epilepsy, strict definition

0.00

0.0

1.0

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

1.0

—

Aortic valve malfunction, age under 60 years

0.00

0.0

1.0

—

Primary coxarthrosis, bilateral

0.00

0.0

1.0

—

Hyperkinetic disorders, excluding more controls

0.00

0.0

1.0

—

Other diseases of the respiratory system

0.00

0.0

1.0

—

Hyperkinetic disorders

0.00

-0.00

0.0

1.0

—

Glomerular disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Injuries to the knee and lower leg

1.00

-0.00

1.1

1.0

—

Valvular operations

0.00

-0.00

0.0

1.0

—

All influenza (not pneumonia)

0.00

-0.00

0.0

1.0

—

Superficial injury of wrist and hand

0.00

-0.00

0.0

1.0

—

Type 1 diabetes, strict definition, subgroup 1

0.00

-0.00

0.0

1.0

—

Type 1 diabetes, strict (exclude DM2)

0.00

-0.00

0.0

1.0

—

Purpura and other haemorrhagic conditions

0.00

-0.00

0.0

1.0

—

Acute and transient psychotic disorders

0.00

-0.00

0.0

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

0.90

-0.00

1.0

1.1

—

Other disorders starting during childhood or adolescence

0.00

-0.00

0.0

1.0

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

-0.00

0.0

1.0

—

Care involving dialysis

0.00

-0.00

0.0

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

0.93

-0.00

1.4

1.0

—

Dyspnoea

1.03

-0.00

1.0

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

0.86

-0.00

1.0

1.1

—

Diabetic maculopathy, excluding more controls

0.00

-0.00

0.0

1.0

—

Abnormal spermatozoa

0.00

-0.00

0.0

1.0

—

Candidiasis

0.00

-0.00

0.0

1.0

—

Personal history of other diseases and conditions

0.00

-0.00

0.0

1.0

—

Adjustment and management of implanted device

0.00

-0.00

0.0

1.0

—

Bitten or struck by other mammals

0.00

-0.00

0.0

1.0

—

Fracture of lumbar spine and pelvis

0.00

-0.00

0.0

1.0

—

Type1 diabetes, definitions combined, early onset

0.00

-0.00

0.0

1.0

—

severe traumatic brain injury, does not include concussion

0.00

-0.00

0.0

1.0

—

Diabetic retinopathy, strict definition

0.00

-0.00

0.0

1.2

—

0.00

-0.00

0.0

1.0

—

Spondylolisthesis/Spondylolysis

0.00

-0.00

0.0

1.0

—

Other disorders starting during childhood or adolecense, excluding more controls

0.00

-0.00

0.0

1.0

—

Perineal laceration during delivery

0.00

-0.00

0.0

1.0

—

Ganglion

0.00

-0.00

0.0

1.0

—

Gout

0.00

-0.00

0.0

1.0

—

Injury of muscle and tendon at wrist and hand level

0.00

-0.00

0.0

1.0

—

Orchitis and epididymitis

0.00

-0.00

0.0

1.0

—

Maternal care for known or suspected fetal abnormality and damage

0.00

-0.00

0.0

1.0

—

Hypertrophy of breast

0.00

-0.00

0.0

1.0

—

Hypertrophy of breast in women and men

0.00

-0.00

0.0

1.0

—

Prolonged pregnancy

0.00

-0.00

0.0

1.0

—

Single delivery by forceps and vacuum extractor

0.00

-0.00

0.0

1.0

—

Other disorders of amniotic fluid and membranes

0.00

-0.00

0.0

1.0

—

Open wound of lower leg

0.00

-0.00

0.0

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

-0.00

0.0

1.0

—

Open wound of forearm

0.00

-0.00

0.0

1.0

—

Thiazolidinediones

0.00

-0.00

0.0

1.0

—

Nonalcoholic fatty liver disease

0.00

-0.00

0.0

1.0

—

Injury of muscle and tendon at lower leg level

0.00

-0.00

0.0

1.0

—

Open wound of ankle and foot

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease, strict definition

0.00

-0.00

0.0

1.0

—

Benign neoplasm of other and unspecified endocrine glands

0.00

-0.00

0.0

1.0

—

Superficial injury of shoulder and upper arm

0.00

-0.00

0.0

1.0

—

Seropositive rheumatoid arthritis

0.00

-0.00

0.0

1.0

—

Superficial injury of thorax

0.00

-0.00

0.0

1.0

—

Glomerular diseases

0.00

-0.00

0.0

1.0

—

Other symptoms and signs involving the urinary system

0.00

-0.00

0.0

1.0

—

Sulfasalazine

0.00

-0.00

0.0

1.0

—

Any mental disorder

1.00

-0.00

1.0

—

D07AA Corticosteroids, weak (group I)

0.00

-0.00

0.0

1.0

—

Nontraumatic intracranial haemmorrhage

0.00

-0.00

0.0

1.0

—

Pain and other conditions associated with female genital organs and menstrual cycle

0.00

-0.00

0.0

1.3

—

Other psoriatic arthropathies

0.00

-0.00

0.0

1.0

—

Nonischemic cardiomyopathy

0.00

-0.00

0.0

1.0

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

0.00

-0.00

0.0

1.0

—

COPD-related respiratory insufficiency

0.00

-0.00

0.0

1.0

—

Premature rupture of membranes

0.00

-0.00

0.0

1.1

—

Other congenital malformations

0.00

-0.00

0.0

1.0

—

L04AD Calcineurin inhibitors

0.00

-0.00

0.0

1.0

—

Other disorders of kidney and ureter

0.00

-0.00

0.0

1.0

—

Psoriatic arthropathies, ICD10

0.00

-0.00

0.0

1.0

—

Zoster [herpes zoster]

0.00

-0.00

0.0

1.0

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

-0.00

0.0

1.0

—

Arthropathic psoriasis

0.00

-0.00

0.0

1.0

—

Melanocytic naevi of trunk

0.00

-0.00

0.0

1.0

—

Embedded teeth, including avohilmo

0.00

-0.00

0.0

1.0

—

Multiple delivery

0.00

-0.00

0.0

1.0

—

Thyrotoxicosis, other and/or unspecified

0.00

-0.00

0.0

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

0.86

-0.00

1.2

1.0

—

Emotional disorders starting during childhood or adolecense, excluding more controls

0.00

-0.00

0.0

1.0

—

Pneumonia, organism unspecified

0.97

-0.00

1.0

1.1

—

Insulin, fast-acting (human)

0.00

-0.00

0.0

1.0

—

Myocardial infarction, unclassifiable

0.00

-0.00

0.0

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

0.99

-0.00

1.0

1.1

—

Disorder of lipoprotein metabolism, unspecified

0.00

-0.00

0.0

1.0

—

Use of hypnotics and sedatives

0.93

-0.00

1.0

1.1

—

Heart failure and antihypertensive medication

0.00

-0.00

0.0

1.0

—

Bipolar affective disorders

0.00

-0.00

0.0

1.0

—

Myocardial infarction, with ST-elevation

0.00

-0.00

0.0

1.0

—

Ventral hernia

0.00

-0.00

0.0

1.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

0.00

-0.00

0.0

1.0

—

Peritonsillar abscess

0.00

-0.00

0.0

1.0

—

Psychiatric diseases

0.96

-0.00

1.0

—

Acute appendicitis, with complications

0.00

-0.00

0.0

1.0

—

Continuous positive airway pressure

0.00

-0.00

0.0

1.0

—

Lesion of ulnar nerve

0.00

-0.00

0.0

1.0

—

All pneumoniae

0.86

-0.00

1.0

1.1

—

Other bacterial diseases

1.02

-0.00

1.2

1.0

—

Alzheimer disease, including avohilmo

0.00

-0.00

0.0

1.0

—

Other complications of labour and delivery, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Retinal detachment with retinal break

0.00

-0.00

0.0

1.0

—

Emotional disorders and disorders of social functioning with onset specific to childhood

0.00

-0.00

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

-0.00

0.0

1.0

—

Persistent mood disorders

0.00

-0.00

0.0

1.0

—

Alzheimer disease

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Transverse colon

0.00

-0.00

0.0

1.0

—

Corneal ulcer

0.00

-0.00

0.0

1.0

—

Mixed conductive and sensorineural hearing loss

0.00

-0.00

0.0

1.0

—

Other and unspecified nonorganic psychotic disorders

0.00

-0.00

0.0

1.0

—

Hypothyroidism, other/unspecified

0.97

-0.00

1.0

1.1

—

Disturbance of activity and attention

0.00

-0.00

0.0

1.0

—

Focal epilepsy

0.00

-0.00

0.0

1.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

-0.00

0.0

1.0

—

Secondary hypertension

0.00

-0.00

0.0

1.0

—

Other (not insulin) diabetes medications

0.93

-0.00

1.2

1.0

—

Dialysis, with operation codes

0.00

-0.00

0.0

1.0

—

AV-block

0.00

-0.00

0.0

1.0

—

Other or unspecified ileus, impaction or obstruction

0.00

-0.00

0.0

1.0

—

Chronic apical periodontitis

0.92

-0.00

1.2

1.0

—

Viral pneumonia

0.00

-0.00

0.0

1.0

—

Any event in cancer register

0.98

-0.00

1.2

1.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.91

-0.00

1.2

1.0

—

Osteoporosis

0.00

-0.00

0.0

1.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

0.00

-0.00

0.0

1.0

—

Other disorders of bladder

0.00

-0.00

0.0

1.0

—

Redundant prepuce, phimosis and paraphimosis

0.00

-0.00

0.0

1.0

—

Burns and corrosions

0.00

-0.00

0.0

1.0

—

Gout, unspecified

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Trichinella spiralis Ab [Titer] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS